bioRxivBiochemistryPreprint
Structural basis for targeting the human T-cell leukemia virus Tax oncoprotein and syntenin-1 interaction using a small molecule
S. Maseko, I. Van Molle, K. Blibek, C. Gorgulla, J. Olivet, J. Blavier, C. Vandermeulen, S. Skupiewski, D. Saha, T. Ntombela, J. Lim, F. Lembo, A. Beauvois, M. Hamaidia, J.-P. Borg, P. Zimmermann, F. Delvigne, L. Willems, J. Van Weyenbergh, D.-K. Kim, F. Dequiedt, H. Arthanari, K. Salehi-Ashtiani, S. Ballet, A. Volkov, J.-C. Twizere
Abstract
Human T-cell leukemia virus type-1 (HTLV-1) is the causative agent of adult T-cell leukemia (ATL). Although ATL is a well-characterized T-cell neoplasm, linked to intermittent expression of the viral Tax-1 protein, there is currently no strategy to target Tax-1 functions using small molecules. Here, we report a comprehensive interaction map between Tax-1 and human PDZ domain-containing proteins (hPDZome). We show that Tax-1 interacts with more than one-third of hPDZome components, including proteins involved in cell cycle, cell-cell junctions, cytoskeleton organization, and membrane complex assembly. Using nuclear magnetic resonance (NMR) spectroscopy, we have determined the structural basis of the interaction between the C-terminal PDZ binding motif (PBM) of Tax-1, and the PDZ domains of syntenin-1, an evolutionary conserved hub that controls exosome trafficking. Finally, we have used confocal imaging, molecular modelling, NMR and mammalian cell-based assays to demonstrate that the Tax-1/syntenin-1 interaction is amenable to small-molecule inhibition. Altogether, our study highlights the biological significance of Tax-PDZ interactome and its interplay with exosome formation. It shows a direct link between extracellular vesicles and HTLV-1 transmission, providing a novel framework for the design of targeted therapies for HTLV-1-induced diseases.
- organism: human
- assay: proteomics
- research focus: drug response / drug discovery
- approach: experimental assay
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Identification of small molecule antivirals against HTLV-1 by targeting the hDLG1-Tax-1 protein-protein interaction
J.-C. Twizere, S. Maseko, … O. Volkov·bioRxiv·Mar 15, 2023
- HTLV-1 Tax induces PINK1-Parkin-dependent mitophagy to mitigate activation of the cGAS-STING pathway
Suchitra Mohanty, Sujit Suklabaidya, … Edward William Harhaj·bioRxiv·Mar 15, 2025
- The E3/E4 ubiquitin conjugation factor UBE4B interacts with and ubiquitinates the HTLV-1 Tax oncoprotein to promote NF-kB activation
E. W. Harhaj, S. Mohanty, … J. Zhang·PLOS PathogensPeer-reviewed·Dec 23, 2020
- HTLV-1 infected T cells cause bone loss via small extracellular vesicles
Nitin Kumar Pokhrel, Amanda R. Panfil, … Deborah V. Novack·Journal of Extracellular VesiclesPeer-reviewed·Oct 1, 2024
- The Human T-cell Leukemia Virus capsid protein is a potential drug target
Ruijie Yu, Prabhjeet K. Phalora, … David A. Jacques·Nature CommunicationsPeer-reviewed·Dec 4, 2025
- Role of the CTCF Binding Site in Human T-Cell Leukemia Virus-1 Pathogenesis
Ancy Joseph, Xiaogang Cheng, … Lee Ratner·PLoS PathogensPeer-reviewed·Jun 3, 2025